Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion type Assertion NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_head.
- NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion description "[These observations suggest that the NAT1*11 variant and the GSTM1 wild-type genotype contribute to a more favorable outcome in patients treated for neuroblastoma and are the first to demonstrate a relationship between NAT1 and GSTM1 genotypes in childhood neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_provenance.
- NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion evidence source_evidence_literature NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_provenance.
- NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion SIO_000772 17700360 NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_provenance.
- NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion wasDerivedFrom gad-20130706 NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_provenance.
- NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_assertion wasGeneratedBy ECO_0000203 NP84231.RAFLrr6EkX1Tk8-ih8dHALcmpWYoVCkhBM1HvBbnoBcdA130_provenance.